Table 1.
Detailed dosing and administration of FIA+VEN regimen with intermittent hemodialysis. Adjustments made according to renal function, performance status, age, and concomitant medications.
| Chemotherapy | Induction dosing and administration€ | Consolidation cycles 2 and 4¥ |
|---|---|---|
| Fludarabine | 15 mg/m2 IV on days 1–3, starting daily at 0530 | 15 mg/m2 IV on days 1–3, starting daily at 1900 |
| Idarubicin | 6 mg/m2 IV on days 1 and 2, administered at 0700 | N/A |
| Cytarabine | 400 mg/m2 on days 1–3; infused over 3 hours, starting 3 hours after completion of fludarabine at 0900 | 400 mg/m2 on days 1–3; infused over 3 hours, starting 3 hours after completion of fludarabine at 2200 |
| Venetoclax | 50 mg PO on day 2, followed by 100 mg PO on day 3 and 200 mg PO on days 4–6; target dose 400 mg reduced for concomitant amiodarone | 100 mg daily on days 1–3; target dose 400 mg reduced due to concomitant voriconazole |
| Hemodialysis | Daily C1D1–C1D4 starting 6 hours after completion of cytarabine infusion at 1800; duration and volume of ultrafiltration tailored to volume status and laboratory studies | Daily D2–4 starting at 0800 |
€ Timing approximated to nearest half hour.
¥ C3 consolidation chemotherapy timing and intermittent hemodialysis (IHD) administration as per induction.